Clinical Trial Update: Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period [Phase 2, Phase 3]

View source ↗

Summary

The document reports completion of a Phase 2/Phase 3 pharmacodynamic trial evaluating a slow-release aspirin formulation in cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Slow Release ASA (acetylsalicylic acid)

Snippet

Sponsor: Rottapharm Spain | Conditions: Cardiovascular Disease | Phase 2, Phase 3 | Status: COMPLETED